Terms: = Ovarian cancer AND SEPT5, HCDCREL-1, 5413, ENSG00000184702, Q99719, PNUTL1, H5
2 results:
1. Tamoxifen-2-hydroxylpropyl-beta-cyclodextrin-aggregated nanoassembly for nonbreast estrogen-receptor-positive cancer therapy.
Shukla J; Sharma U; Kar R; Varma IK; Juyal S; Jagannathan NR; Bandopadhyaya GP
Nanomedicine (Lond); 2009 Dec; 4(8):895-902. PubMed ID: 19958226
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract] [Full Text] [Related]